2022

2022

In the context of the war crisis in Ukraine, Antibiotice manufactures for the entire population of Romania, in record time, tablets with potassium iodide of 65 mg necessary in the event of a nuclear attack and provide support to the Ukrainian population, consisting of medicines of strict necessity.

Antibiotice inaugurates the most modern solid and semi-solid topical pharmaceuticals factory in Europe – a total investment of 20 million euros – and obtains the Good Manufacturing Practice certification for the new site from the National Agency for Medicines and Medical Devices of Romania.

Antibiotice, one of the first Romanian joint stock companies present on the capital market, celebrates 25 years since its listing on the Bucharest Stock Exchange. Transparency of investor communication and the quality of financial reporting were rewarded with the first prize from the investor public and the 10th grade in the VEKTOR ranking for the 3rd consecutive year, ranking compiled by the Romanian Investor Relations Association.

See all news ▸